The synthesis of reliable candidate molecules is an essential first step in the development of new medicines. At UCB, Patrick Cerfontaine is responsible for the process by which these compounds are produced and tested. In an article on LabInsights, he describes how modern laboratory equipment enhances efficiency and control within the research process.
For these research processes, UCB uses reactor technology from Büchi Glas Uster, custom-configured and supplied by Suurmond.
The systems are tailored to the specific working methods and safety requirements of the UCB laboratory.
This enables optimal process control and reproducibility – factors that are of paramount importance for high-quality R&D in the pharmaceutical industry.
“The strength lies in the combination of proven Büchi technology and the right configuration for our application,” says Cerfontaine.
For many years, Suurmond has been supporting UCB with expert advice, service and bespoke equipment configurations. This long-standing partnership illustrates the mutual trust and shared focus on quality, safety and sustainability.
The combination of Büchi technology and Suurmond expertise provides UCB with a robust foundation for advanced research.
“We value the open collaboration with Patrick Cerfontaine and his team,” says Chaïma Ben Ahmed of Suurmond.
“By listening carefully to the researchers’ needs, we can supply equipment that contributes to reliable results and flexible R&D processes.”
With extensive knowledge of process equipment and bespoke configurations, Suurmond helps research organisations optimise their laboratories for the science of tomorrow.
Read the full article in Dutch on LABinsights.nl › Synthesising candidate molecules as the first step towards a medicine.
Or download it here.
Want to read more about experiences with Büchi technology? Click here for the interview (in Dutch) with Leon Stelten of Alcami on flexible scale-up technology.